Maternal serum ADMA is not associated with proinflammatory cytokines or C-reactive protein during normal pregnancy

Cytokine

Volumn 46, Issue 2, 2009, Pages 216-221

  Valtonen, Pirjo ^a   Punnonen, Kari ^a   Saarelainen, Heli ^a   Heiskanen, Nonna ^a   Raitakari, Olli T ^b   Viikari, Jorma S A ^b   Lyyra Laitinen, Tiina ^a   Laitinen, Tomi ^a   Heinonen, Seppo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

ADMA; C reactive protein; Interleukin 6; Pregnancy; Tumor necrosis factor

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; N(G),N(G) DIMETHYLARGININE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FINLAND; HEMODILUTION; HUMAN; IMMUNE SYSTEM; KIDNEY CLEARANCE; MAJOR CLINICAL STUDY; MATERNAL SERUM; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY; SMOKING; THIRD TRIMESTER PREGNANCY;

ADULT; ARGININE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CREATININE; CYTOKINES; ENZYME INHIBITORS; FEMALE; GESTATIONAL AGE; HUMANS; INTERLEUKIN-6; LIPIDS; PREGNANCY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65049085333     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.01.011     Document Type: Article

References (48)

1. Saarelainen H., Laitinen T., Raitakari O.T., Juonala M., Heiskanen N., Lyyra-Laitinen T., et al. Pregnancy-related hyperlipidemia and endothelial function in healthy women. Circ J 70 (2006) 768-772
2. Zavalza-Gomez A.B., Anaya-Prado R., Rincon-Sanchez A.R., and Mora-Martinez J.M. Adipokines and insulin resistance during pregnancy. Diabetes Res Clin Pract 80 (2008) 8-15
3. Aagaard-Tillery K.M., Silver R., and Dalton J. Immunology of normal pregnancy. Semin Fetal Neonatal Med 11 (2006) 279-295
4. Elenkov I.J., and Chrousos G.P. Stress hormones, Th1/Th2 patterns, Pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 10 (1999) 359-368
5. Wegmann T.G., Lin H., Guilbert L., and Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?. Immunol Today 14 (1993) 353-356
6. Sharma A., Satyam A., and Sharma J.B. Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 58 (2007) 21-30
7. Wilke C., Renz H., Tekesin I., Hellmeyer L., Herz U., and Schmidt S. Suppression of IL-2 and IFN-gamma production in women with spontaneous preterm labor. J Perinat Med 34 (2006) 20-27
8. Qiu C., Luthy D.A., Zhang C., Walsh S.W., Leisenring W.M., and Williams M.A. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens 17 (2004) 154-160
9. Hvilsom G., Thorsen P., Jeune B., and Bakketeig L.S. C-reactive protein: a serological marker for preterm delivery?. Acta Obstet Gynecol Scand 81 (2002) 424-429
10. Tsatsaris V., Tarrade A., Merviel P., Garel J.M., Segond N., Jullienne A., et al. Calcitonin gene-related peptide (CGRP) and CGRP receptor expression at the human implantation site. J Clin Endocrinol Metab 87 (2002) 4383-4390
11. Clarke S. Protein methylation. Curr Opin Cell Biol 5 (1993) 977-983
12. Ogawa T., Kimoto M., and Sasaoka K. Purification and properties of a new enzyme, NG,NG-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem 264 (1989) 10205-10209
13. Cartwright J.E., Holden D.P., and Whitley G.S. Hepatocyte growth factor regulates human trophoblast motility and invasion: a role for nitric oxide. Br J Pharmacol 128 (1999) 181-189
14. Ayling L.J., Whitley G.S., Aplin J.D., and Cartwright J.E. Dimethylarginine dimethylaminohydrolase (DDAH) regulates trophoblast invasion and motility through effects on nitric oxide. Hum Reprod 21 (2006) 2530-2537
15. Holden D.P., Fickling S.A., Whitley G.S., and Nussey S.S. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am J Obstet Gynecol 178 (1998) 551-556
16. Fickling S.A., Williams D., Vallance P., Nussey S.S., and Whitley G.S. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 342 (1993) 242-243
17. Savvidou M.D., Hingorani A.D., Tsikas D., Frölich J.C., Vallance P., and Nicolaides K.H. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361 (2003) 1511-1517
18. Ito A., Tsao P.S., Adimoolam S., Kimoto M., Ogawa T., and Cooke J.P. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99 (1999) 3092-3095
19. Mookerjee R.P., Dalton R.N., Davies N.A., Hodges S.J., Turner C., Williams R., et al. Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure. Liver Transpl 13 (2007) 400-405
20. Ablij H., and Meinders A. C-reactive protein: history and revival. Eur J Intern Med 13 (2002) 412-422
21. Bae S.W., Stuhlinger M.C., Yoo H.S., Yu K.H., Park H.K., Choi B.Y., et al. Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment. Am J Cardiol 95 (2005) 729-733
22. Kocyigit Y., Atamer Y., Atamer A., Tuzcu A., and Akkus Z. Changes in serum levels of leptin, cytokines and lipoprotein in pre-eclamptic and normotensive pregnant women. Gynecol Endocrinol 19 (2004) 267-273
23. Raitakari O.T., Juonala M., Rönnemaa t., Keltinkangas-Järvinen L., Räsänen L., Pietikäinen M., et al. Cohort profile: The Cardiovascular Risk in Young Finns Study. Int J Epidemiol 37 (2008) 1220-1226
24. Juonala M., Viikari J.S., Hutri-Kähönen N., Pietikäinen M., Jokinen E., Taittonen L., et al. The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference. J Intern Med 255 (2004) 457-468
25. Teerlink T., Nijveldt R.J., de Jong S., and van Leeuwen P.A. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303 (2002) 131-137
26. Valtonen P., Karppi J., Nyyssönen K., Valkonen V.P., Halonen T., and Punnonen K. Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum. J Chromatogr B Anal Technol Biomed Life Sci 828 (2005) 97-102
27. Juonala M., Viikari J.S.A., Rönnemaa T., Taittonen L., Marniemi J., and Raitakari O.T. Childhood C-reactive protein in predicting CRP and carotid intima-media thickness in adulthood: The Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol 26 (2006) 1883-1888
28. Maeda T., Yoshimura T., and Okamura H. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, in maternal and fetal circulation. J Soc Gynecol Investig 10 (2003) 2-4
29. Siroen M.P., Teerlink T., Bolte A.C., van Elburg R.M., Richir M.C., Nijveldt R.J., et al. No compensatory upregulation of placental dimethylarginine dimethylaminohydrolase activity in preeclampsia. Gynecol Obstet Invest 62 (2006) 7-13
30. Achan V., Broadhead M., Malaki M., Whitley G., Leiper J., MacAllister R., et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23 (2003) 1455-1459
31. Leiper J., Nandi M., Torondel B., Murray-Rust J., Malaki M., O'Hara B., et al. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med 13 (2007) 198-203
32. Holden D.P., Cartwright J.E., Nussey S.S., and Whitley G.S. Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine. Circulation 108 (2003) 1575-1580
33. Cockell A.P., and Poston L. Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension 30 (1997) 247-251
34. Stewart F.M., Freeman D.J., Ramsay J.E., Greer I.A., Caslake M., and Ferrell W.R. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab 92 (2007) 969-975
35. Leiper J., and Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 43 (1999) 542-548
36. Sacks G.P., Seyani L., Lavery S., and Trew G. Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum Reprod 19 (2004) 1025-1030
37. Kluft C., Leuven J.A., Helmerhorst F.M., and Krans H.M. Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment. Vascul Pharmacol 39 (2002) 149-154
38. Viikari L.A., Huupponen R.K., Viikari J.S., Marniemi J., Eklund C., Hurme M., et al. Relationship between leptin and C-reactive protein in young Finnish adults. J Clin Endocrinol Metab 92 (2007) 4753-4758
39. Khaodhiar L., Ling P.R., Blackburn G.L., and Bistrian B.R. Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. JPEN J Parenter Enteral Nutr 28 (2004) 410-415
40. Hwang H.S., Kwon J.Y., Kim M.A., Park Y.W., and Kim Y.H. Maternal serum highly sensitive C-reactive protein in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet 98 (2007) 105-109
41. Hirano T. Interleukin 6 and its receptor: ten years later. Int Rev Immunol 16 (1998) 249-284
42. Santhanam U., Avila C., Romero R., Viguet H., Ida N., Sakurai S., et al. Cytokines in normal and abnormal parturition: elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infection. Cytokine 3 (1991) 155-163
43. Murtha A.P., Greig P.C., Jimmerson C.E., and Herbert W.N. Maternal serum interleukin-6 concentration as a marker for impending preterm delivery. Obstet Gynecol 91 (1998) 161-164
44. Aris A., Lambert F., Bessette P., and Moutquin J.M. Maternal circulating interferon-gamma and interleukin-6 as biomarkers of Th1/Th2 immune status throughout pregnancy. J Obstet Gynaecol Res 34 (2008) 7-11
45. Castell J.V., Gomez-Lechon M.J., David M., Hirano T., Kishimoto T., and Heinrich P.C. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 232 (1988) 347-350
46. Varfolomeev E.E., and Ashkenazi A. Tumor necrosis factor: an apoptosis JuNKie?. Cell 116 (2004) 491-497
47. Jirik F.R., Podor T.J., Hirano T., Kishimoto T., Loskutoff D.J., Carson D.A., et al. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 142 (1989) 144-147
48. Ellis J., Wennerholm U.B., Bengtsson A., Lilja H., Pettersson A., Sultan B., et al. Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand 80 (2001) 602-608